Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Healthcare Biotechnology
Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Noxopharm Ltd > Drill Results Out
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Comment by Sophia123on Jan 16, 2015 11:29am
85 Views
Post# 23327929

RE:Drill Results Out

RE:Drill Results Out Newz!!!  YEAH!!!!  Those intervalz look kinda short huh??  Kinda in ball park of average grade for concept pit and stuff but short interval on long drills.  

Look at the headline report grade of -- 68.73 g/t Au over 4.1 m in hole MB-14-342 at a vertical depth of 145 m.

145 meterz hasto be striped to get about 2 ounzes of gold per tone.  Thatz not THAT great huh???  Like over 47 stories down and down thru waste rock. :(  

If you averige out that intervil acrosst the 145 meters you get way way WAY below averige pit grade of resource estimate.  I dunno.

Have the BEST day EVERYONE!!!  YeAH!!!!  ^_^

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities